Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone

IUBMB Life

Volumn 66, Issue 10, 2014, Pages 686-693

  Ashraf, Jalaluddin M ^a   Ahmad, Saheem ^b   Rabbani, Gulam ^c   Jan, Arif Tasleem ^a   Lee, Eun Ju ^a   Khan, Rizwan Hasan ^c   Choi, Inho ^a  

^a Yeungnam University   (South Korea)

^b INTEGRAL UNIVERSITY   (India)

^c ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

3 deoxyglucosone; Advanced glycation end products; Glycation; N carboxymethyllysine; Pentosidine

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ARGININE; CARBONYL DERIVATIVE; HISTONE H2A; LYSINE; PENTOSIDINE; 3-DEOXYGLUCOSONE; DEOXYGLUCOSE; HISTONE; N(6)-CARBOXYMETHYLLYSINE;

AMADORI REARRANGEMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FLUORESCENCE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; THYMUS; ANALOGS AND DERIVATIVES; CHEMISTRY; CIRCULAR DICHROISM; GLYCOSYLATION; HUMAN; INFRARED SPECTROSCOPY; METABOLISM;

ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; DEOXYGLUCOSE; FLUORESCENCE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HISTONES; HUMANS; LYSINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84915775777     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1318     Document Type: Article

References (63)

1. Lendl, F. and Schleicher, E. (1990) New aspects of the Maillard reaction in foods and in the human body. Angew. Chem. 29, 565-706.
2. Monnier, V. (1989) The Maillard reaction in aging: diabetes and nutrition. Prog. Clin. Biol. Res. 304, 1-22.
3. Reddy, S., Buchler, J., Wells-Knecht, K., Thorpe, S., and Baynes, J. (1995) NEpsilon carboxymethyl lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34, 10872-10878.
4. Ahmad M. I., Ahmad, S., and Moinuddin (2011). Preferential recognition of methylglyoxal modified calf thymus DNA by circulating autoantibodies in cancer patients. Ind. J. Biochem. Biophys. 48, 290-296.
5. Ashraf, J. M., Arif, B., Dixit, K., Moinuddin, and Alam, K. (2012) Physicochemical analysis of structural changes in DNA modified with glucose. Int. J. Biol. Macromol. 51, 604-611.
6. Ahmad, S., Akhter, F., Shahab, U., Moinuddin, and Khan, M. S. (2013) Studies on glycation of human low density lipoprotein: a functional insight into physico-chemical analysis. Int. J. Biol. Macromol. 62, 167-171.
7. Akhter, F., Khan, S. M., Shahab, U., Moinuddin, and Ahmad S. (2013). Biophysical characterization of ribose induced glycation: a mechanistic study on DNA perturbations. Int. J. Biol. Macromol. 58, 206-210.
8. Beisswenger, P., Makita, Z., Curphey, T., Moore, L., Jean, S., et al. (1995) Formation of immunochemical advanced glycation end products precedes and correlates with early manifestations renal and retinal disease in diabetes. Diabetes 44, 824-829.
9. King, G. and Brownlee, M. (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol. Metab. Clin. North. Am. 25, 255-270.
10. Lyons, T. and Jenkins, A. (1997) Glycation, oxidation and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev. 5, 365-391.
11. Niwa, T. (1999) 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication. J. Chromatogr. B 731, 23-36.
12. Niwa, T., Katsuzaki, T., Miyazaki, S., Momoi, T., Akiba, T., et al. (1997) Amyloid & Beta;2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int. 51, 187-194.
13. Anet, E. F. L. J. (1964) 3-Deoxyglycosuloses (3-deoxyglucosones) and the degradation of carbohydrates. Adv. Carbohydr. Chem. Biochem. 19, 181-219.
14. Weenen, H. and Tjan, S. B. (1992) Analysis, structure and reactivity of 3-deoxyglucosone. ACS Symp. Ser. 490, 217-231.
15. Wolffe, A. (1998) Chromatin. p. 7. Academic Press, San Diego (CA).
16. Liebich, H. M., Gesele, E., Wirth, C., Woll, J., Jobst, K., et al. (1992) Nonenzymatic glycation of histones. Biol. Mass Spectrom. 22, 121-123.
17. Gugliucci, A. (1994) Advanced glycation of rat liver histone octamers: an in vitro study. Biochem. Biophys. Res. Commun. 203, 588-593.
18. Cervantes-Laurean, D., Jacobson, E. L., and Jacobson, M. K. (1996) Glycation and Glycoxidation of Histones by ADP-ribose. J. Biol. Chem. 271, 10461-10469.
19. Bucala, R., and Cerami, A. (1992) Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv. Pharmacol. 23, 1-34.
20. Bojanovic, J. J., Jevtovic, A. D., Pantic, V. S., Dugandzic, S. M., and Jovanovic, D. S. (1970) Thymus nucleoproteins. Thymus histones in young and adult rats. Gerontologia (Basel) 16, 304-312.
21. Udenfriend, S., Stein, S., Bohlen, P., Dairman, W., and Weigele, M. (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178, 871-872.
22. Lorenzen, A. and Kennedy, S. W. (1993) A fluorescence-based protein assay for use with a microplate reader. Anal. Biochem. 214, 346-348.
23. Smith, R. E. and MacQuarrie, R. (1978) A sensitive fluorometric method for the determination of arginine using 9,10-phenanthrenequinone. Anal. Biochem. 90, 246-255.
24. Johnson, R. N., Metcalf, P. A., and Baker, J. R. (1982) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 127, 87-95.
25. Levine, R. L., Williams, J., Stadtman, E. R., and Shacter, E. (1994) Carbonyl assay for determination of oxidatively modified proteins. Methods Enzymol. 233, 346-357.
26. Misselwitz, J., Franke, S., Kauf, E., John, U., and Stein, G. (2002) Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr. Nephrol. 17, 316-321.
27. Ahmed, N., Argirov, O. K., Minhas, H. S., Cordeiro, C. A., and Thornalley, P. J. (2002) Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to N-epsilon-carboxymethyl-lysine-and N-epsilon-(1-carboxyethyl)lysine-modified albumin. Biochem. J. 364, 1-14.
28. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., et al. (1996) Ne-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35, 8075-8083.
29. Nagai, R., Matsumoto, K., Ling, X., Suzuki, H., Araki, T., et al. (2000) Glycoaldehyde, a reactive intermediate for advanced glycation end products, play an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49, 1714-1723.
30. Afrin, S., Riyazuddeen, Rabbani, G., and Khan, R. H. (2014) Spectroscopic and calorimetric studies of interaction of methimazole with human serum albumin. J. Lumin. 15, 1219-1223.
31. Rabbani, G., Ahmad, E., Zaidi, N., and Khan, R.H. (2011) pH-dependent conformational transitions in conalbumin (ovotransferrin), a metalloproteinase from hen egg white. Cell. Biochem. Biophys. 61, 551-560.
32. Brownlee, M. (2005) The pathobiology of diabetic complications-a unifying mechanism. Diabetes 54, 1615-1625.
33. Huebschmann, G., Regensteiner, J. G., Vlassara, H., and Reusch, J. E. (2006) Diabetes and advanced glycoxidation end products. Diabetes Care 29, 1420-1432.
34. Ahmed, N. and Thornalley, J. (2007) Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab. 9, 233-245.
35. Skovsted, I. C., Christensen, M., and Breinholt, J. (1998) Characterisation of a novel age-compound derived from lysine and 3-deoxyglucasone. Cell. Mol. Biol. 44, 1159-1163.
36. Wells-Knecht, K. J., Brinkmann, E., Wells-Knecht, M. C., Litchfield, J. E., Ahmed, M. U., et al. (1996) New biomarkers of maillard reaction damage to proteins. Nephrol. Dial. Transplant. 11, 41-47.
37. Baynes, J. W. and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications a new perspective on an old paradigm. Diabetes 48, 1-9.
38. Mlakar, A. and Spiteller, G. (1994) Re-investigation of lipid per-oxidation of linoleic acid. Biochim. Biophys. Acta 1214, 209-220.
39. Sima, A. A. and Sugimoto, K. (1999) Experimental diabetic neuropathy: an update. Diabetologia 42, 773-788.
40. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., et al. (2000) Normalising mitochondrial superoxide production blocks three pathways of hyperglycaemia induced damage. Nature 404, 787-789.
41. Thornalley P. J. (2005) Dicarbonyl intermediates in the Maillard reaction. Ann. NY Acad. Sci. 1043, 111-117.
42. Hodge, J. R. (1955) The Amadori rearrangement. Adv. Carbohydr. Chem. 10, 169-205.
43. Stefek, M., Trnkova, Z., and Krizanova, L. (1999) 2,4-Dinitrophenylhydrazine carbonyl assay in metal-catalysed protein glycoxidation. Redox. Rep. 4, 43-48.
44. Raheem, M., Iram, S., Mohd Sajid, K., Khan M. S., Shukla, A. R., et al. (2014). Glycation-assisted synthesized gold nanoparticles inhibit growth of bone cancer cells. Colloid Surf. B. Biointerface 117, 473-479.
45. Jairajpuri, D. S., Fatima, S., and Saleemuddin, M. (2007) Immunoglobulin glycation with fructose: a comparative study. Clin. Chim. Acta 378, 86-92.
46. Schmitt, A., Gasic-Milenkovic, J., and Schmitt, J. (2005) Characterization of advanced glycation end products: mass changes in correlation to side chain modifications. Anal. Biochem. 346, 101-106.
47. Schmitt, A., Schmitt, J., Munch, G., and Gasic-Milenkovic, J. (2005) Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Anal. Biochem. 338, 201-215.
48. Ahmad, S., Moinuddin, Dixit, K., Shahab, U., Alam, K., et al. (2011) Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu21. Biochem. Biophys. Res. Commun. 407, 568-574.
49. Mustafa, I., Ahmad, S., Dixit, K., Moinuddin, Ahmad, J., and Ali, A. (2012) Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetes mellitus patients. Diabetes Res. Clin. Pract. 95, 98-104.
50. Ahmad, S., Moinuddin, Shahab, U. K., Habib, S., Khan, M. S., et al. (2014) Glycoxidative damage to human DNA: neo-antigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes. Glycobiology 24, 281-291.
51. Kessel, L., Kalinin, S., Nagaraj, R. H., Larsen, M., and Johansson, L. B. (2002) Time-resolved and steady-state fluorescence spectroscopic studies of the human lens with comparison to argpyrimidine, pentosidine and 3-OHkynurenine. Photochem. Photobiol. 76, 549-554.
52. Amiri Majd, A. M., Goodarzi, M. T., Hassanzadeh, T., Tavilani1, H., and Karimi, J. (2013) In vitro study of glycation of pyruvate kinase and its effect on activity and proteolytic resistance in absence and presence of aminoguanidine. J. Basic Appl. Sci. Res. 3, 878-884.
53. Grandhee, S. K. and Monnier, V. M. (1991) Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose and ascorbate as pentosidine precursors. J. Biol. Chem. 266, 11649-11653.
54. Degenhardt, T. P., Thorpe, J. S., and Baynes, R. W. (1998) Chemical modification of proteins by methylglyoxal. Cell. Mol. Biol. (Noisy-le-Grand) 44, 1139-1145.
55. Rabbani, G., Kaur, J., Ahmad, E., Khan, R. H., and Jain, S.K. (2014) Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi (S. Typhi). Appl. Microbiol. Biotechnol. 98, 2533-2543.
56. Corbin, J., M-ethot, N., Wang, H. H., Baenziger, J. E., and Blanton, M. P. (1998) Secondary structure analysis of individual transmembrane segments of the nicotinic acetylcholine receptor by circular dichroism and Fourier transform infrared spectroscopy. J. Biol. Chem. 273, 771-777.
57. Rabbani, G., Ahmad, E., Zaidi, N., Fatima, S., and Khan, R. H. (2012) pH induced molten globule state of Rhizopus niveus lipase is more resistant against thermal and chemical denaturation than its native state. Cell. Biochem. Biophys. 62, 487-499.
58. Khalifah, R. G., Baynes, J. W., and Hudson, B. G. (1999) Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. Biochem. Biophys. Res. Commun. 257, 251-258.
59. Dill, K. A. (1990) Dominant forces in protein folding. Biochemistry 29, 7133-7155.
60. Fojo, A. T., Whitney, P. L., and Awad, W. M. Jr. (1983) Effects of acetylation and guanidination on alkaline conformations of chymotrypsin. Arch. Biochem Biophys. 224, 636-642.
61. Zheng, N., Yang, T., Liang, M., Zhang, H., Li, L., et al. (2010) Characterization of protein in old myocardial infarction by FTIR micro-spectroscopy. J. Huazhong Univ. Sci. Technol. 30, 546-550.
62. Liu, Y., Xie, M. X., Kang, J., and Zheng, D. (2003) Studies on the interaction of total saponins of panax notoginseng and human serum albumin by Fourier transform infrared spectroscopy. Spectrochim. Acta A 59, 2747-2758.
63. Ahmad, S., Moinuddin, Khan, R. H., and Ali, A. (2012) Physicochemical Studies on Glycation-induced Structural Changes in Human IgG. IUBMB Life 64, 151-156.